Published online Aug 18, 2020. doi: 10.5500/wjt.v10.i8.215
Peer-review started: February 5, 2020
First decision: April 1, 2020
Revised: June 29, 2020
Accepted: July 1, 2020
Article in press: July 1, 2020
Published online: August 18, 2020
Processing time: 183 Days and 18.7 Hours
Individuals with benign kidney disorders undergoing nephrectomy have three possibilities: Autotransplantation, with a certain risk of complications, but without a clear benefit; discarding the kidney; or living kidney donation.
To investigate whether patients with benign kidney disorders and a medical indication for nephrectomy are suitable as unspecified live kidney donors.
We searched all clinical data from 1994-2019 for unspecified donors and their transplant recipients (n = 160). Nine of these 160 donors had pre-existing kidney disorders necessitating nephrectomy and had decided to donate their kidney anonymously after discussing the possibility of kidney donation. We studied the clinical course of these nine donating patients and their transplant recipients.
Seven of nine donating patients indicated unbearable loin pain as the main complaint, one donating patient refused ureterocutaneostomy and one had two aneurysms of the renal artery. Postoperatively, seven donating patients described absence of pain and one a significant reduction after the nephrectomy. The average 1-year creatinine level in the donating patients was 88 µmol/L and after a median of 6.9 years the average creatinine level was 86.6 µmol/L. In the transplant recipients, one major complication occurred which led to death and in one transplant recipient graft function failed to normalize at first but has been stable for nine years now. Currently, all transplant recipients are off dialysis.
Our data show that patients undergoing nephrectomy as part of treatment in selected kidney disorders can function as live kidney donors.
Core tip: The aim of this study was to investigate if a kidney after nephrectomy in patients with a benign kidney disorder could be transplanted successfully as an unspecified live donor kidney transplant. Follow-up showed that the 1-year average creatinine level was 88 µmol/L and after a median of 6.9 years an average creatinine level of 86.6 µmol/L was reached in these donating patients. In seven of nine donating patients the absence of pain was described. Transplant recipients showed an average creatinine level of 164.5 µmol/L with a median follow-up of 7.7 years. Furthermore, all transplant recipients are currently not on dialysis. Our data show the safety and feasibility of transplanting kidneys from patients with a medical indication for nephrectomy and enlarging the live kidney donor pool.